Antithrombotic treatment after Intracerebral Haemorrhage
The aims of this project are to describe the prescription pattern of antithrombotic therapy in intracerebral haemorrhage survivors in Swedish clinical practice, and the effect of antithrombotic treatment in patients with concurring atrial fibrillation.
Patients with intracerebral haemorrhages (ICH) often have cogent indications for antithrombotic therapy (AT) such as atrial fibrillation (AF). This represents a therapeutic dilemma as antiplatelets (AP) and anticoagulants (AC) are often perceived as contraindicated following ICH. International guidelines give varying recommendations.
We will use the Swedish stroke register (Riksstroke), other national health data registers at the National Board of Health and Welfare to describe the prescription pattern of AT therapy in ICH survivors in Swedish clinical practice, and the effect of antithrombotic treatment in ICH survivors with concurring AF.
Title of Project
Antitrhombotic treatment after Intracerebral hemorrhage
01/01/2015 - 12/31/2018
Cardiology, Cardiovascular medicine, Neurology
Head of research
Marie Eriksson, Department of Statistics